发明名称 |
Crystalline forms of [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one |
摘要 |
The present invention relates to crystalline forms containing [1S-(1alpha,3alpha,4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one represented by formula I; processes for the production thereof; pharmaceutical compositions thereof; methods for preparing the pharmaceutical composition; and the use of these crystalline forms in the treatment of hepatitis B viral infections.
|
申请公布号 |
US2007060599(A1) |
申请公布日期 |
2007.03.15 |
申请号 |
US20050222597 |
申请日期 |
2005.09.09 |
申请人 |
DIMARCO JOHN D;GOUGOUTAS JACK Z |
发明人 |
DIMARCO JOHN D.;GOUGOUTAS JACK Z. |
分类号 |
A61K31/522;C07D473/04 |
主分类号 |
A61K31/522 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|